MedPath

PMS-NABUMETONE

PMS-NABUMETONE

Discontinued
DIN Number

02238760

Drug Class

Human

Market Date

N/A

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238760
AIG Number0122821002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AX01 NABUMETONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NABUMETONEActive
Strength: 750 MG / TAB
Monograph: NABUMETONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.